Genedrive PLC (LON:GDR) CEO David Budd joins Proactive London's Katie Pilbeam to discuss their strong momentum and latest collaboration.
genedrive and Beckman Coulter have accelerated their relationship as the duo are to target the US and Europe with their coronavirus testing technology.
The agreement allows the American biomedical company to sell and distribute genedrive's COVID-19 PCR test, the 96 SARS-CoV-2 kit which is ideally suited for use on Beckman’s high throughput robotic Biomek i7 instrument.